 MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 PRNewswire -- Alterity Therapeutics ASX: ATH, NASDAQ: ATHE Alterity or the Company today announced it has commenced enrolling patients with Multiple System Atrophy MSA in its bioMUSE Study in the United States. BioMUSE is a... 